The potential role of the combined PARP-1 and VEGF inhibition in severe SARS-CoV-2 (COVID-19) infection

The potential role of the combined PARP-1 and VEGF inhibition in severe SARS-CoV-2 (COVID-19) infection

Introduction: During the evolution of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, several drug candidates have been proposed for repositioning towards a quest for more effective treatments. Methodology: We reviewed recent literature (Pubmed, Google, Clinicalt...

Full description

Saved in:
Bibliographic Details
Main Authors: Dimitra Ioanna Lampropoulou, Vanessa Meletia Bala, Eleni Zerva, Evangelia Pliakou, Dimitrios Filippou, Maria Gazouli, Gerasimos Aravantinos
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2022-01-01
Series:Journal of Infection in Developing Countries
Subjects:
SARS-CoV-2
PARP-1 inhibitors
VEGF
bevacizumab
olaparib
Online Access:https://jidc.org/index.php/journal/article/view/15386
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jidc.org/index.php/journal/article/view/15386

Similar Items